Your session is about to expire
← Back to Search
Vasoconstrictor
Phenylephrine for Low Blood Pressure
Phase 4
Recruiting
Research Sponsored by West-Ward Pharmaceutical
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Subject is scheduled for a procedure that requires general or neuraxial anesthesia
Subjects with controlled diabetes prior to entry must have a mean systolic/diastolic office blood pressure ≤128/78 mmHg (sitting, after 5 minutes of rest)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up screening up to day 3
Awards & highlights
Study Summary
This trial is designed to study the effects of phenylephrine hydrochloride injection on blood pressure in adolescents undergoing general or neuraxial anesthesia.
Who is the study for?
This trial is for kids aged 12-16 who need anesthesia for a procedure and have low blood pressure. They should be generally healthy, not pregnant, and not on blood pressure meds. Kids with serious health issues or recent infections can't join.Check my eligibility
What is being tested?
The study tests how Phenylephrine Hydrochloride Injection affects blood pressure in young patients under anesthesia. It looks at dosage effects, changes in heart rate and blood pressure, response times, safety, and how the body processes the drug.See study design
What are the potential side effects?
Possible side effects of Phenylephrine may include rapid heartbeat, headache, nervousness, restlessness, nausea or vomiting; rare but more serious reactions could involve high blood pressure or irregular heart rhythm.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am scheduled for surgery that needs general or spinal anesthesia.
Select...
My diabetes is under control and my blood pressure is 128/78 mmHg or lower.
Select...
I am between 12 and 16 years old.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ screening up to day 3
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~screening up to day 3
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Plasma Phenylephrine (PE) concentrations will be measured using a validated liquid chromatography/mass spectrometry (LCMS/MS) assay.
Trial Design
1Treatment groups
Experimental Treatment
Group I: PhenylephrineExperimental Treatment1 Intervention
Phenylephrine Hydrochloride Injection, USP (United States Pharmacopeia) 10 mg/mL label claim
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Phenylephrine
FDA approved
Find a Location
Who is running the clinical trial?
West-Ward PharmaceuticalLead Sponsor
3 Previous Clinical Trials
1,921 Total Patients Enrolled
Cesar Ormeno, MDStudy DirectorPRA Health Sciences
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have taken a pregnancy test that was negative.I am not pregnant, nursing, and I use effective birth control.I am scheduled for surgery that needs general or spinal anesthesia.I cannot take certain medications to control my blood pressure.I haven't had a serious infection in the last 4 weeks.I am on medication for high blood pressure.My diabetes is under control and my blood pressure is 128/78 mmHg or lower.I do not have any serious health issues that could affect my participation in the study.The person is very sick and is expected to pass away within two days.You have hepatitis B or C.I am between 12 and 16 years old.
Research Study Groups:
This trial has the following groups:- Group 1: Phenylephrine
Awards:
This trial has 4 awards, including:- All Individual Drugs Already Approved - Therapies where all constituent drugs have already been approved are likely to have better-understood side effect profiles.
- Drug Has Already Been Approved - The FDA has already approved this drug, and is just seeking more data.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger